With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...
In the current market session, Regeneron Pharmaceuticals Inc. REGN share price is at $695.58, after a 0.06% decrease. Over the past month, the stock spiked by 2.93%, but over the past year, it ...
Zacks.com on MSN23h
Pharma Stock Roundup: EU Nod to MRK's Welireg, IONS' Q4 Results & MoreThis week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...
This was the stock's third consecutive day of gains.
Regeneron is also embroiled in a securities fraud class action lawsuit stemming from a significant stock price drop on October 31, 2024. Shares plunged $84.59 that day, wiping out approximately $9 ...
On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...
Regeneron has won a court ruling that will make it harder for U.S. authorities to win a lawsuit accusing it of paying illegal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback